Ovid Therapeutics, Inc. (OVID)
2.80
-0.13
(-4.44%)
USD |
NASDAQ |
Aug 28, 16:00
2.85
+0.05
(+1.79%)
After-Hours: 06:53
Ovid Therapeutics Market Cap : 517.32M for Aug. 28, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 28, 2026 | 517.32M |
| August 27, 2026 | 541.33M |
| August 26, 2026 | 532.10M |
| August 25, 2026 | 537.64M |
| August 24, 2026 | 521.01M |
| August 21, 2026 | 517.32M |
| August 20, 2026 | 506.23M |
| August 19, 2026 | 541.33M |
| August 18, 2026 | 524.71M |
| August 17, 2026 | 533.94M |
| August 14, 2026 | 522.86M |
| August 13, 2026 | 517.32M |
| August 12, 2026 | 484.06M |
| August 11, 2026 | 476.67M |
| August 10, 2026 | 484.06M |
| August 07, 2026 | 439.91M |
| August 06, 2026 | 443.26M |
| August 05, 2026 | 438.24M |
| August 04, 2026 | 424.86M |
| August 03, 2026 | 389.73M |
| July 31, 2026 | 371.33M |
| July 30, 2026 | 396.42M |
| July 29, 2026 | 383.04M |
| July 28, 2026 | 394.75M |
| July 27, 2026 | 393.08M |
| Date | Value |
|---|---|
| July 24, 2026 | 389.73M |
| July 23, 2026 | 401.44M |
| July 22, 2026 | 398.09M |
| July 21, 2026 | 403.11M |
| July 20, 2026 | 385.55M |
| July 17, 2026 | 408.13M |
| July 16, 2026 | 409.80M |
| July 15, 2026 | 416.49M |
| July 14, 2026 | 411.48M |
| July 13, 2026 | 406.46M |
| July 10, 2026 | 421.51M |
| July 09, 2026 | 434.89M |
| July 08, 2026 | 456.64M |
| July 07, 2026 | 461.66M |
| July 06, 2026 | 436.57M |
| July 02, 2026 | 449.95M |
| July 01, 2026 | 448.27M |
| June 30, 2026 | 449.95M |
| June 29, 2026 | 454.96M |
| June 26, 2026 | 426.53M |
| June 25, 2026 | 404.78M |
| June 24, 2026 | 418.17M |
| June 23, 2026 | 388.06M |
| June 22, 2026 | 376.35M |
| June 18, 2026 | 379.70M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 5.011B |
| Alnylam Pharmaceuticals, Inc. | 31.71B |
| Anika Therapeutics, Inc. | 282.38M |
| Savara, Inc. | 1.080B |
| Vericel Corp. | 2.095B |
Market Cap Related Metrics
| PS Ratio | 215.09 |
| Price to Book Value | 2.465 |
| Price | 2.80 |
| Earnings Yield | -9.05% |